These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28619754)

  • 1. Antitumor Effect of the Atypical Retinoid ST1926 in Acute Myeloid Leukemia and Nanoparticle Formulation Prolongs Lifespan and Reduces Tumor Burden of Xenograft Mice.
    El-Houjeiri L; Saad W; Hayar B; Aouad P; Tawil N; Abdel-Samad R; Hleihel R; Hamie M; Mancinelli A; Pisano C; El Hajj H; Darwiche N
    Mol Cancer Ther; 2017 Oct; 16(10):2047-2057. PubMed ID: 28619754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model.
    Nasr RR; Hmadi RA; El-Eit RM; Iskandarani AN; Jabbour MN; Zaatari GS; Mahon FX; Pisano CC; Darwiche ND
    Int J Cancer; 2015 Aug; 137(3):698-709. PubMed ID: 25557649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem-like cells.
    Bahmad HF; Samman H; Monzer A; Hadadeh O; Cheaito K; Abdel-Samad R; Hayar B; Pisano C; Msheik H; Liu YN; Darwiche N; Abou-Kheir W
    Mol Carcinog; 2019 Jul; 58(7):1208-1220. PubMed ID: 30883933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
    Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
    Di Francesco AM; Meco D; Torella AR; Barone G; D'Incalci M; Pisano C; Carminati P; Riccardi R
    Biochem Pharmacol; 2007 Mar; 73(5):643-55. PubMed ID: 17150196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma.
    El Hajj H; Khalil B; Ghandour B; Nasr R; Shahine S; Ghantous A; Abdel-Samad R; Sinjab A; Hasegawa H; Jabbour M; Hall WW; Zaatari G; Dbaibo G; Pisano C; Bazarbachi A; Darwiche N
    Blood; 2014 Sep; 124(13):2072-80. PubMed ID: 25035162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization of ovarian carcinoma cells to the atypical retinoid ST1926 by the histone deacetylase inhibitor, RC307: enhanced DNA damage response.
    Zuco V; Benedetti V; De Cesare M; Zunino F
    Int J Cancer; 2010 Mar; 126(5):1246-55. PubMed ID: 19676051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models.
    Aouad P; Saikali M; Abdel-Samad R; Fostok S; El-Houjeiri L; Pisano C; Talhouk R; Darwiche N
    Anticancer Drugs; 2017 Aug; 28(7):757-770. PubMed ID: 28471809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.
    Basma H; Ghayad SE; Rammal G; Mancinelli A; Harajly M; Ghamloush F; Dweik L; El-Eit R; Zalzali H; Rabeh W; Pisano C; Darwiche N; Saab R
    Int J Cancer; 2016 Mar; 138(6):1528-37. PubMed ID: 26453552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity.
    Valli C; Paroni G; Di Francesco AM; Riccardi R; Tavecchio M; Erba E; Boldetti A; Gianni' M; Fratelli M; Pisano C; Merlini L; Antoccia A; Cenciarelli C; Terao M; Garattini E
    Mol Cancer Ther; 2008 Sep; 7(9):2941-54. PubMed ID: 18790775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST1926 inhibits glioma progression through regulating mitochondrial complex II.
    De L; Yuan T; Yong Z
    Biomed Pharmacother; 2020 Aug; 128():110291. PubMed ID: 32526455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models.
    Pisano C; Vesci L; Foderà R; Ferrara FF; Rossi C; De Cesare M; Zuco V; Pratesi G; Supino R; Zunino F
    Ann Oncol; 2007 Sep; 18(9):1500-5. PubMed ID: 17698835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: the role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasome.
    Fratelli M; Fisher JN; Paroni G; Di Francesco AM; Pierri F; Pisano C; Godl K; Marx S; Tebbe A; Valli C; Gianni M; Stravalaci M; Gobbi M; Terao M; Garattini E
    Eur J Cancer; 2013 Apr; 49(6):1491-500. PubMed ID: 23245330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis.
    Garattini E; Parrella E; Diomede L; Gianni' M; Kalac Y; Merlini L; Simoni D; Zanier R; Ferrara FF; Chiarucci I; Carminati P; Terao M; Pisano C
    Blood; 2004 Jan; 103(1):194-207. PubMed ID: 12958071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adamantyl-substituted retinoid-related molecules induce apoptosis in human acute myelogenous leukemia cells.
    Farhana L; Dawson MI; Xia Z; Aboukameel A; Xu L; Liu G; Das JK; Hatfield J; Levi E; Mohammad R; Fontana JA
    Mol Cancer Ther; 2010 Nov; 9(11):2903-13. PubMed ID: 21062916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and pharmacological bases of the antitumor activity of a novel adamantyl retinoid, ST1926.
    Pisano C; Merlini L; Penco S; Carminati P; Zunino F
    J Chemother; 2004 Nov; 16 Suppl 4():74-6. PubMed ID: 15688616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models.
    Di Francesco AM; Ubezio P; Torella AR; Meco D; Pierri F; Barone G; Cusano G; Pisano C; D'Incalci M; Riccardi R
    Invest New Drugs; 2012 Aug; 30(4):1319-30. PubMed ID: 21633925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to the atypical retinoid ST1926 in SK-N-AS cells selected the subline rAS-ST with enhanced sensitivity to ATRA mediated by not conventional mechanisms: DNA damage, G2 accumulation and late telomerase inhibition.
    Di Francesco AM; Cusano G; Franzese O; Orienti I; Falconi M; Vesci L; Riccardi R
    Toxicol In Vitro; 2015 Oct; 29(7):1628-38. PubMed ID: 26096597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ST1926 Nanoparticle Drug Formulation Enhances Drug Therapeutic Efficiency in Colorectal Cancer Xenografted Mice.
    Assi S; Hayar B; Pisano C; Darwiche N; Saad W
    Nanomaterials (Basel); 2024 Aug; 14(17):. PubMed ID: 39269042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.